Ali Gholamrezaei

Ali Gholamrezaei

Auto-generated profile, based on publicly available information

Ali Gholamrezaei

Pain Management Research Institute, Kolling Institute, Faculty of Medicine and Health, The University of Sydney

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2015 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
MTMehdi Torki
Mehdi Torki
AGAli Gholamrezaei
Ali Gholamrezaei
LMLeila Mirbagher
Leila Mirbagher
MDManijeh Danesh
Manijeh Danesh
SKSara Kheiri
Sara Kheiri
MEMohammad Hassan Emami
Mohammad Hassan Emami

16 June 2011 in Lupus
Verified
Journal Article
Closed access
ZBZs Bonakdar
Zs Bonakdar
LJL Jahanshahifar
L Jahanshahifar
FJF Jahanshahifar
F Jahanshahifar
AGA Gholamrezaei
A Gholamrezaei
Evidence has shown a relationship between vitamin D deficiency and systemic lupus erythematosus (SLE). We evaluated the frequency of vitamin D deficiency and its association with disease activity in new cases of SLE. Women with newly diagnosed SLE, based on the American College of Rheumatology (ACR) criteria, were enrolled consecutively. Those receiving vitamin D supplements and postmenopausal women were not included. Disease activity was measured by the BILAG index (2004) and serum concentration of 25-hydroxyvitamin D (25[OH]D) was measured by radioimmunoassay method. Forty SLE patients with mean age of 25.3 ± 4.2 years were studied. Severe, moderate, and mild vitamin D deficiency, corresponding to serum 25[OH]D concentrations of <12.5, 12.5–24.9, and 25–39.9 nmol/l, were found in 12.5%, 62.5%, and 17.5% of the patients, respectively. Serum 25[OH]D concentration was inversely correlated with the British Isles Lupus Assessment Group (BILAG) index score (r = −0.486, p = 0.001). Those with a more severe vitamin D deficiency had also higher concentrations of liver enzymes (p < 0.05), lower serum albumin and hemoglobin concentrations (p < 0.05), and higher titers of antibodies to double-stranded DNA (ds-DNA) (p < 0.001). This study showed that most of the SLE patients in our society have vitamin D deficiency at the time of diagnosis that is associated with a higher disease activity. Routine screening for vitamin D deficiency and its prompt treatment in patients with newly diagnosed SLE is recommended.

24 February 2013 in Helicobacter
Verified
Journal Article
Closed access
PDF file
ASAhmad Shavakhi
Ahmad Shavakhi
ETElham Tabesh
Elham Tabesh
AYArezoo Yaghoutkar
Arezoo Yaghoutkar
HHHouriye Hashemi
Houriye Hashemi
FTFaezeh Tabesh
Faezeh Tabesh
AGAli Gholamrezaei
Ali Gholamrezaei

22 September 2014 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
HRHamidreza Roohafza
Hamidreza Roohafza
ZPZ. Pourmoghaddas
Z. Pourmoghaddas
HSH. Saneian
H. Saneian
AGA. Gholamrezaei
A. Gholamrezaei

4 April 2022 in BMJ
Verified
Journal Article
Open access
PDF file
NANicholas Avery
Nicholas Avery
AMAmy G McNeilage
Amy G McNeilage
FSFiona Stanaway
Fiona Stanaway
CAClaire E Ashton-James
Claire E Ashton-James
FBFiona M Blyth
Fiona M Blyth
PGPaul Glare
Paul Glare
Objective: To review interventions to reduce long term opioid treatment in people with chronic non-cancer pain, considering efficacy on dose reduction and discontinuation, pain, function, quality of life, withdrawal symptoms, substance use, and adverse events. Design: Systematic review and meta-analysis of randomised controlled trials and non-randomised studies of interventions. Data sources: Medline, Embase, PsycINFO, CINAHL, and the Cochrane Library searched from inception to July 2021. Reference lists and previous reviews were also searched and experts were contacted. Eligibility criteria for study selection: Original research in English. Case reports and cross sectional studies were excluded. Data extraction and synthesis: Two authors independently selected studies, extracted data, and used the Cochrane risk-of-bias tools for randomised and non-randomised studies (RoB 2 and ROBINS-I). Authors grouped interventions into five categories (pain self-management, complementary and alternative medicine, pharmacological and biomedical devices and interventions, opioid replacement treatment, and deprescription methods), estimated pooled effects using random effects meta-analytical models, and appraised the certainty of evidence using GRADE (grading of recommendations, assessment, development, and evaluation). Results: Of 166 studies meeting inclusion criteria, 130 (78%) were considered at critical risk of bias and were excluded from the evidence synthesis. Of the 36 included studies, few had comparable treatment arms and sample sizes were generally small. Consequently, the certainty of the evidence was low or very low for more than 90% (41/44) of GRADE outcomes, including for all non-opioid patient outcomes. Despite these limitations, evidence of moderate certainty indicated that interventions to support prescribers’ adherence to guidelines increased the likelihood of patients discontinuing opioid treatment (adjusted odds ratio 1.5, 95% confidence interval 1.0 to 2.1), and that these prescriber interventions as well as pain self-management programmes reduced opioid dose more than controls (intervention v control, mean difference –6.8 mg (standard error 1.6) daily oral morphine equivalent, P<0.001; pain programme v control, −14.31 mg daily oral morphine equivalent, 95% confidence interval −21.57 to −7.05). Conclusions: Evidence on the reduction of long term opioid treatment for chronic pain continues to be constrained by poor study methodology. Of particular concern is the lack of evidence relating to possible harms. Agreed standards for designing and reporting studies on the reduction of opioid treatment are urgently needed. Review registration: PROSPERO CRD42020140943.

9 June 2014 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
LMLeila Mirbagher
Leila Mirbagher
AGAli Gholamrezaei
Ali Gholamrezaei
NHNaeimeh Hosseini
Naeimeh Hosseini
ZBZahra Sayed Bonakdar
Zahra Sayed Bonakdar